CDKN2A and neoplasm: This difference seems unrelated to primary tumor grade (five/six grade 2/3 tumors developed a CDKN2A/RB1 alteration upon progression to grade 4 vs. six/six grade 2/3 tumors without progression-related alteration, respectively, p = 1.0, Fisher’s exact test).